Current and Emerging Clinical Trials in Mitochondrial Disease
Needs Statement
Clinical geneticists, residents, fellows, laboratory directors, genetic counselors, nurse practitioners, nurses, and medical and genetic counseling students need to receive regular updates on advances in clinical genetics research and in genomic diagnostics and therapeutics. Special emphasis will be given to fetal therapy for genetic disorders, therapeutic applications of the CRISPR/Cas9 system, and methods for decoding exome and genome sequences. The series aims to expand the knowledge of learners, provide the skills to interpret genomic studies, enhance the quality of medical genetics care, and improve patient outcomes.
Target Audience
Physicians, medical students, fellows, residents, nurses, and other health professionals.
Learning Objectives
At the conclusion of the activity, the participants should be able to:
- Recognize the potential therapeutic targets that could be used in mitochondrial disorders.
- Critique the results of existing clinical trials for mitochondrial disease.
- Analyze the potential efficacy of novel therapeutic interventions in mitochondrial disorders.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
- 1.00 Social Work
Price
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact cpd@bcm.edu.